Gaussion Secures $28.0M Investment

4BIO Capital

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, please visit www.4biocapital.com

UBDS Digital

UBDS Digital, a brand on a mission to deliver unparalleled client value, unmatched employee experience, and to make a meaningful difference in society. We understand your needs deeply and are laser focused on outcomes, never compromising on quality or security. We are your visionary partner, taking on complex work, creating smarter solutions, with innovative technologies, for the best results and producing lasting progress, for all. In September 2024, UBDS Digital became B Corp Certified. This certification affirms our commitment to purpose-driven practices and using business as a force for positive change. We are proud to align each project with the broader mission of benefiting all stakeholders, not just shareholders, and to be part of a movement of forward-thinking companies that prioritise societal impact.

Oxford Drug Design

Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates with highly innovative chemical scaffolds and modes of action.

Dartle

Dartle is a sports technology platform that offers a suite of tools and services to sports academies to manage their operations and track athlete performance data. The platform is built using modern cloud technologies and offers a highly secure, scalable, and reliable solution to its customers. Dartle uses machine learning algorithms to analyze performance data and provides actionable insights to academies to help them optimize their athlete development programs. The platform also enables academies to create historical performance portfolios for their athletes, which can be used by recruiters to discover new talent. The platform is highly configurable and can be easily customized to meet the specific needs of each academy. Overall, Dartle is a powerful and flexible platform that can help sports academies streamline their operations and achieve better performance outcomes. Dartle provides sports academies with a system that allows to manage their operations while also giving them a flexible framework for long term athlete development and data capture. Our analytics then helps academies to improve the performance of their young athletes. As a consequence, a historical performance portfolio for a player is created which moves with the player across academies and also allows for player's global visibility

Conduct

Conduct’s mission is to make IT the innovation powerhouse of every company. Our agentic AI delivers an in-depth understanding of legacy enterprise software. For the first time ever, you can chat directly with your systems to resolve major business issues in days instead of months. We’re starting where it matters most: SAP, the OS of global business. Conduct makes the unmanageable, manageable. Setting the stage for the next era of productivity growth with AI-powered Enterprise System Intelligence.